C-reactive protein - To screen or not to screen?.

被引：91

作者：

Mosca, L ^{[1
]}

机构：

[1] Columbia Univ, New York, NY 10032 USA

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 2002年 / 347卷 / 20期

关键词：

D O I：

10.1056/NEJMe020127

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1615 / 1617

页数：4

共 16 条

[1] Alpha-Tocopherol Beta Carotene Cancer Prevention Study Group, 1994, N Engl J Med, V330, P1029, DOI 10.1056/NEJM199404143301501
[2] [Anonymous], 1997, Eur Heart J, V18, P1569
[3] Need to test the arterial inflammation hypothesis
Bhatt, DL
Topol, EJ
[J]. CIRCULATION, 2002, 106 (01) : 136 - 140
[4] C-reactive protein, insulin resistance, central obesity, and coronary heart disease risk in Indian Asians from the United Kingdom compared with European whites
Chambers, JC
Eda, S
Bassett, P
Karim, Y
Thompson, SG
Gallimore, JR
Pepys, MB
Kooner, JS
[J]. CIRCULATION, 2001, 104 (02) : 145 - 150
[5] Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses
Danesh, J
Whincup, P
Walker, M
Lennon, L
Thomson, A
Appleby, P
Gallimore, JR
Pepys, MB
[J]. BMJ-BRITISH MEDICAL JOURNAL, 2000, 321 (7255): : 199 - 204
[6] EUROASPIRE Study Grp, 1998, EUR HEART J, V19, P356
[7] Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly
Harris, TB
Ferrucci, L
Tracy, RP
Corti, MC
Wacholder, S
Ettinger, WH
Heimovitz, H
Cohen, HJ
Wallace, R
[J]. AMERICAN JOURNAL OF MEDICINE, 1999, 106 (05) : 506 - 512
[8] Haverkate F, 1997, LANCET, V349, P462, DOI 10.1016/S0140-6736(96)07591-5
[9] A SURVEY OF 246 SUGGESTED CORONARY RISK-FACTORS
HOPKINS, PN
WILLIAMS, RR
[J]. ATHEROSCLEROSIS, 1981, 40 (01) : 1 - 52
[10] Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels
Ridker, PM
Rifai, N
Pfeffer, MA
Sacks, FM
Moye, LA
Goldman, S
Flaker, GC
Braunwald, E
[J]. CIRCULATION, 1998, 98 (09) : 839 - 844

← 1 2 →